| Year |
Citation |
Score |
| 2016 |
Almaliti J, Al-Hamashi AA, Negmeldin AT, Hanigan CL, Perera L, Pflum MK, Casero RA, Tillekeratne LM. Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue. Journal of Medicinal Chemistry. PMID 27809521 DOI: 10.1021/Acs.Jmedchem.6B01271 |
0.533 |
|
| 2014 |
Bhansali P, Hanigan CL, Perera L, Casero RA, Tillekeratne LM. Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups. European Journal of Medicinal Chemistry. 86: 528-41. PMID 25203782 DOI: 10.1016/J.Ejmech.2014.09.009 |
0.574 |
|
| 2013 |
Murray-Stewart T, Hanigan CL, Woster PM, Marton LJ, Casero RA. Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism Molecular Cancer Therapeutics. 12: 2088-2099. PMID 23943804 DOI: 10.1158/1535-7163.Mct-13-0418 |
0.532 |
|
| 2013 |
Jin L, Hanigan CL, Wu Y, Wang W, Park BH, Woster PM, Casero RA. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1 (DNA methyltransferase 1)-independent manner Biochemical Journal. 449: 459-468. PMID 23072722 DOI: 10.1042/Bj20121360 |
0.526 |
|
| 2012 |
Yun J, Johnson JL, Hanigan CL, Locasale JW. Interactions between epigenetics and metabolism in cancers. Frontiers in Oncology. 2: 163. PMID 23162793 DOI: 10.3389/Fonc.2012.00163 |
0.428 |
|
| 2011 |
Bhansali P, Hanigan CL, Casero RA, Tillekeratne LM. Largazole and analogues with modified metal-binding motifs targeting histone deacetylases: synthesis and biological evaluation. Journal of Medicinal Chemistry. 54: 7453-63. PMID 21936551 DOI: 10.1021/Jm200432A |
0.562 |
|
| 2008 |
Hanigan CL, Van Engeland M, De Bruine AP, Wouters KA, Weijenberg MP, Eshleman JR, Herman JG. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1. Gastroenterology. 135: 1654-1664.e2. PMID 18834886 DOI: 10.1053/J.Gastro.2008.07.078 |
0.408 |
|
| 2002 |
Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genetics. 31: 175-9. PMID 12021783 DOI: 10.1038/Ng886 |
0.37 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2004 |
Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Research. 64: 3022-9. PMID 15126337 DOI: 10.1158/0008-5472.Can-03-1880 |
0.245 |
|
| 2006 |
Robles AI, Wright MH, Gandhi B, Feis SS, Hanigan CL, Wiestner A, Varticovski L. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6547-56. PMID 17085670 DOI: 10.1158/1078-0432.CCR-06-1178 |
0.213 |
|
| 2014 |
Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, Le Gallo M, Program NI, Zhang S, Cruz P, Cherukuri PF, Hansen NF, McManus KJ, Godwin AK, Sgroi DC, et al. Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. Plos One. 8: e63313. PMID 23755103 DOI: 10.1371/Journal.Pone.0063313 |
0.158 |
|
| 2011 |
Bell DW, Sikdar N, Lee KY, Price JC, Chatterjee R, Park HD, Fox J, Ishiai M, Rudd ML, Pollock LM, Fogoros SK, Mohamed H, Hanigan CL, Zhang S, et al. Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. Plos Genetics. 7: e1002245. PMID 21901109 DOI: 10.1371/Journal.Pgen.1002245 |
0.132 |
|
| Hide low-probability matches. |